‹ Return to Directory

Muscle Weakness Due to Spinal Cord Cell Disease

Anne Connolly and Michele Yang

Anne Connolly has worked in the neuromuscular field for twenty-six years at Washington University School of Medicine in Saint Louis. Her early research looked at mechanisms of disease progression in mouse models of Duchenne and Congenital muscular dystrophy.  More recent work relates to developing skeletal, pulmonary and cardiac outcomes in infants, boys, and men with Duchenne Muscular Dystrophy (DMD). Over the last 10 years, she has been the site PI for multiple studies involving children with DMD, congenital muscular dystrophy, and spinal muscular atrophy. She is the lead PI for a MDA funded multicenter trial of infants and toddlers with DMD. Community work has included service to the local Muscular dystrophy association as Camp Doctor for more than two decades. She has also collaborated in developing standard of care guidelines for treatment of children with DMD, congenital muscular dystrophy, and spinal muscular atrophy.

Michele Yang, MD Michele Yang, MD is an Assistant Professor  Pediatrics and Neurology at the University of Colorado Denver and Director of the Electromyography Laboratory at Children’s Hospital of Colorado. Dr. Yang’s clinical research focus has been on therapeutic treatments for neuromuscular disease. She is the site PI for studies involving children with Duchenne muscular dystrophy and congenital muscular dystrophy.

DESCRIPTION AND SYMPTOMS

What is Motor Neuron Disease?

Motor neurons are the cells in the spinal cord and brainstem that control voluntary muscle movement. When these cells are damaged, the muscles become weak and get small (atrophy). The muscles of the arms and legs are often involved, and even muscles of breathing and swallowing can be involved. Motor neuron diseases refers to disorders in which there is progressive weakness of muscles due to a problem with the motor neuron. The most common motor neuron disorder in children is spinal muscular atrophy (SMA). In adults, it is amyotrophic lateral sclerosis (ALS also known as Lou Gehrig’s disease). Spinal muscular atrophy will not be discussed here as it is reviewed in another section of this website. However, there are other types of motor neuron disease that happen because of miscoding of the genes or because of exposures that damage the motor neurons.

Description

Motor neuron disease in children occurs in two ways:

  1. it can result from miscoding in the genes (genetic cause); or
  2. it can result from an exposure to infections, toxins, or injury.

The symptoms common to motor neuron disorders from either cause include muscle twitching (fasciculations), low tone, weakness, and low muscle bulk. These symptoms can occur at any age from neonates to adulthood. In general, the earlier the symptoms are seen, the more severe the course of weakness will be. In some people, the symptoms start when they are teens or young adults, and these patients have mild weakness and continue to be able to walk. The history and physical examination are crucial to figuring out the cause. Some questions your doctor may ask you:

  • when was the weakness first noted?
  • what has the progression been?
  • is there any family history of people with similar weakness?

Testing may include an electrophysiologic tests called electromyography (EMG) and nerve conduction studies (NCS), which tests the function of the nerve and the muscles; magnetic resonance imaging (MRI); and blood tests for genetic causes.

Physical Abnormalities

Weakness and loss of muscle bulk are the hallmarks of motor neuron disease. If the weakness has been long-standing and severe, then contractures of the joints can occur. In babies, if there are multiple contractures of the joints, the term arthrogryposis multiplex congenita is used to describe contractures that start from birth. In older children, the contractures may be more mild and present only in the heel cords.

What other symptoms can occur with hereditary motor neuron disease?

Children whose motor neuron disease results from miscoding of genes can have other neurological symptoms associated with their weakness, such as:

  • brain malformations
  • seizures
  • spasticity
  • ataxia
  • spasticity
  • contractures
  • abnormal movements

Weakness of the muscles of breathing and swallowing can also impact weight gain and growth.

CAUSATION

What causes motor neuron disease in children?

There are many known genetic and environmental causes of motor neuron disease. However, many times, despite extensive investigations for causes, the cause is not identified. Known causes include:

  • Genetic: There are many known genetic causes of motor neuron disease, and many more genes being described every year.
  • Acquired infectious: Polio was once one of the most common causes of acquired motor neuron disease. With the introduction of the poliovirus vaccine, polio as a cause of sudden onset weakness has been reduced, except in areas with low immunization rates. Other infections that can cause symptoms that look like polio include West Nile virus, HIV, HTLV-1, and enteroviruses D68 and 71.
  • Acquired vascular: Strokes involving the blood vessels that supply the motor neuron cells in the spinal cord can cause sudden onset weakness.
  • Acquired trauma: Sudden onset weakness can also happen with birth trauma, falls, motor vehicles accidents, blows to the spinal column, and, rarely cases after exposure to electrical injury or lightning, resulting in isolated injury of the motor neurons in the spinal cord.
  • Unknown causes: Monomelic amyotrophy is a rare form of motor neuron disease where weakness occurs in a restricted number of muscles. Most cases are sporadic, though a familial form has been reported.

Genetic causes

Spinal muscular atrophy (SMA)-like

  • Distal SMA type 1
  • Spinal muscular atrophy with respiratory distress type 1
  • Spinal muscular atrophy with respiratory distress type 2
  • Scapuloperoneal SMA
  • X-linked SMA with arthrogryposis
SMA-like with central nervous system manifestations

  • Pontocerebellar hypoplasia (PCH) type 1A
  • PCH2
  • PCH1C
  • Leukoencephalopathy with dystonia and motor neuropathy
  • Hexosaminidase A deficiency, juvenile form
  • Mitochondrial membrane protein associated neurodegeneration
  • Achalasia-addisonism-alacrimia
  • SMA with myoclonic epilepsy
SMA with predominant bulbar involvement

  • Brown-Vialetto-Van Laere
  • Fazio-Londe disease
  • Spinal and bulbar muscular atrophy
Arthrogryposis

  • Lethal congenital contracture syndrome (LCCS) type 1
  • LCCS2
  • SMA with lower extremity predominance (SMA-LED)
SMA with distal weakness

  • Distal SMA types 1,2,3,4,5
Amyotrophic lateral sclerosis (ALS)

  • ALS types 2,4,5,6,16
Mobius syndrome

Acquired causes

Infections

  • Poliovirus
  • West Nile virus
  • HIV
  • HTLV-1
  • Enterovirus D68
  • Enterovirus 71
Vascular etiologies

  • Arteriovenous malformations
  • Stroke
Trauma

  • Electrical injury
  • Lightning
  • Car accidents
  • Birth trauma
  • Blows to the spinal cord
Unknown

  • Monomelic amyotrophy

Laboratory Investigations

The history and physical examination are crucial to determining what laboratory studies are needed to make a diagnosis. Brain and spine imaging can identify areas of stroke or injury, and identify brain malformations that can be seen with some forms of motor neuron disease. An electrophysiologic test is used to diagnose problems in the muscle and nerve. In the nerve conduction study portion of this test, electrodes are placed over the arms and legs, and a small electrical stimulus is sent down the nerves and recorded by the electrodes. The response recorded indicates the health of the nerves.  In the electromyography portion of the test, a small microphone is placed in the muscle to record the electrical signals in the muscle. In people with motor neuron disease, this test will show abnormalities in the muscle because of damage to the motor neuron. It is important to note that the results of this test need to be interpreted in the context of the history and physical examination. Therefore, results should be interpreted by the neurologist before a diagnosis is made.

Other testing can include blood tests to look at breakdown of muscle (creatine kinase) and to perform genetic testing for specific gene mutations.

Therapeutic Intervention

In general, there are no cures for motor neuron diseases. Treatment is focused on supportive care, to make sure that breathing is safe and nutrition is optimized. Quality of life has been shown to be improved with breathing and nutrition are optimized. This may require breathing support with a mask or through a tracheostomy, and may be only at night or require around the clock support. Nutritional support for these patients may require additional calories, but if the muscles of swallowing are too weak to allow people to chew or swallow, then feeding through a gastrostomy tube may be required.

Prognosis

The prognosis for these patients is variable and depends on the underlying cause. In general, for those children with acquired motor neuron disorders, the weakness is maximal at the onset of the injury or exposure, with incomplete improvement in the weakness over time. In children with genetic causes of motor neuron disease, the weakness is progressive. If the symptoms present in infancy, then the course tends to be more severe and progressive. If they present in their teens, patients are more likely to continue to be able to walk and have normal lifespans.

Glossary

Amyotrophy-Muscle wasting or weakness

Atrophy-when motor neurons in the cord are damaged the muscles become weak and shrink in size

Fasciculations-muscle twitching when motor neurons connected to muscle are damaged

Motor Neuron-A nerve cell located in the spinal cord or brainstem which extends through the nerve to supply muscle.

Fasciculation’s-muscle twitching when motor neurons connected to muscle are damaged

References

Detailed descriptions of specific disorders may be found on the Muscular Dystrophy Association website (MDA.org).

Family Stories

Resources